|
KMID : 1039120120010010070
|
|
Clinical and Experimental Vaccine Research
2012 Volume.1 No. 1 p.70 ~ p.76
|
|
|
Development of a novel vaccine against canine parvovirus infection with a clinical isolate of the type 2b strain
|
|
Park Seon-Ah
Park Seung-Yong
Song Chang-Seon
Choi In-Soo
Kim Hwi-Yool
Lee Joong-Bok
Lee Nak-Hyung
|
|
|
Abstract
|
|
|
Purpose: In spite of an extensive vaccination program, parvoviral infections still pose a major threat to the health of dogs.
Materials and Methods: We isolated a novel canine parvovirus (CPV) strain from a dog with enteritis. Nucleotide and amino acid sequence analysis of the isolate showed that it is a novel type 2b CPV with asparagine at the 426th position and valine at the 555th position in VP2. To develop a vaccine against CPV infection, we passaged the isolate 4 times in A72 cells.
Results: The attenuated isolate conferred complete protection against lethal homologous CPV infection in dogs such that they did not develop any clinical symptoms, and their antibody titers against CPV were significantly high at 7-11 days post infection.
Conclusion: These results suggest that the virus isolate obtained after passaging can be developed as a novel vaccine against paroviral infection.
|
|
|
KEYWORD
|
|
|
Canine parvoviral infection, Vaccines, Novel type 2b, Dogs, Clinical isolate
|
|
|
FullTexts / Linksout information
|
|
|
|
|
|
Listed journal information
|
|
  
|